Memphis, TN 的 急性髓系白血病 臨床試驗
15 項針對 急性髓系白血病 的研究正在 Memphis（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
招募中2 期
- Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
- Baptist Memorial Hospital and Cancer Center-Desoto, Southhaven · 距離 12 英里
- Baptist Memorial Hospital and Cancer Center-Collierville, Collierville · 距離 23 英里
A Study to Find the Highest Dose of Cedazuridine and Decitabine Combination With Filgrastim as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With High-Risk Acute Myeloid Leukemia
招募中1 期
- Saint Jude Children's Research Hospital, Memphis
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
招募中2 期
- Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
- Baptist Memorial Hospital and Cancer Center-Desoto, Southhaven · 距離 12 英里
- Baptist Memorial Hospital and Cancer Center-Collierville, Collierville · 距離 23 英里
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
招募中2 期
- Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
- Baptist Memorial Hospital and Cancer Center-Desoto, Southhaven · 距離 12 英里
- Baptist Memorial Hospital and Cancer Center-Collierville, Collierville · 距離 23 英里
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
招募中2 期
- Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
- Baptist Memorial Hospital and Cancer Center-Desoto, Southhaven · 距離 12 英里
- Baptist Memorial Hospital and Cancer Center-Collierville, Collierville · 距離 23 英里
A Study of Venetoclax in Combination With Conventional Chemotherapy in Pediatric Patients With Acute Myeloid Leukemia
招募中2 期
- St. Jude Children's Research Hospital, Memphis
A Prospective Trial of Dalbavancin-Based Prophylaxis in Children and Adolescents With High-Risk Leukemia
招募中1 期
- St. Jude Children's Research Hospital, Memphis
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
招募中1/2 期
- Saint Jude Children's Research Hospital, Memphis
Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
招募中3 期
- St. Jude Children's Research Hospital, Memphis
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
招募中3 期
- Baptist Clinical Research Institute, Memphis
Eltanexor and Venetoclax in Relapsed or Refractory Myelodysplastic Syndrome and Acute Myeloid Leukemia
招募中1 期
- Baptist Health Care Corporation, Memphis
Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia
招募中1 期
- St. Jude Children's Research Hospital, Memphis
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
招募中觀察性研究
- St. Jude Childrens Research Hospital, Memphis
Study of Talazoparib in Combination With Chemotherapy in Relapsed Pediatric AML to Determine Safety and Efficacy
招募中1 期
- St. Jude Children's Research Hospital, Memphis
CAR T-cell Therapy Directed to CD70 for Pediatric Patients With Hematological Malignancies
招募中1 期
- St. Jude Children's Research Hospital, Memphis
其他城市的 急性髓系白血病 試驗
- Houston, TX85 項研究
- New York City, NY51 項研究
- Boston, MA44 項研究
- Seattle, WA41 項研究
- Baldwin Park, CA40 項研究
- Columbus, OH35 項研究
- Philadelphia, PA34 項研究
- Durham, NC33 項研究
- Atlanta, GA31 項研究
- Tampa, FL29 項研究
- Chicago, IL26 項研究
- Portland, OR25 項研究
Memphis 的其他研究
- 癌症（所有類型）31 項研究
- 非小細胞肺癌23 項研究
- 乳癌22 項研究
- 肺癌18 項研究
- 鐮狀細胞病18 項研究
- 急性淋巴母細胞性白血病16 項研究
- 心臟衰竭13 項研究
- 軟組織肉瘤11 項研究
- 黑色素瘤11 項研究
- 前列腺癌11 項研究
- 大腸直腸癌11 項研究
- 骨肉瘤10 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。